Skip to main content
HYPR logo

HYPR · Hyperfine, Inc. · Metrics

Track HYPR — free
$0.77 0.00 (-0.41%) At close · Oct 20
Market Cap
$82.42M
Shares
106.05M
Volume · Oct 20 273.87K Avg daily vol (3M) 736.04K

HYPR metrics

76 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.77
Market cap
$82.42M

Price action

20 metrics
Price change (1W)
-14.3%
Price change (30D)
-0.5%
Price change (3M)
-20.6%
Price change (6M)
-39.8%
Price change (YTD)
-20.6%
Price change (1Y)
-40.2%
Trailing year
Price change (5Y)
-92.2%
52-week high
$1.87
52-week low
$0.75
Change from 52-week high
-58.4%
Change from 52-week low
+3.0%
Annualized volatility
70.9%
Annualized volatility (3M)
49.0%
Beta
2.0
RSI (14D)
41.1
Price vs SMA 50
-7.8%
Price vs SMA 200
-32.1%
Avg volume (3M)
746,655
Relative volume
0.5
Average dollar volume
$666,434

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
106.05M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
3.0×
reciprocal yield 33.2%
EV / EBITDA
—
EV / EBIT
—
P / sales
4.8×
reciprocal yield 20.7%
P / book
2.2
reciprocal yield 45.9%
FCF yield
-34.4%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-43.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-09
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
51.4%
Operating margin
-203.3%
Trailing 12 months
Net margin
-210.8%
Gross profit (TTM)
$8.50M
Operating profit (TTM)
−$33.62M
Net income (TTM)
−$34.85M
Trailing 12 months
Diluted EPS (TTM)
$-0.37
FCF margin
-166.5%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
$-1.03
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+44.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$16.54M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+27.8%
Year over year · more shares
Revenue CAGR (3Y)
+25.8%
Revenue CAGR (5Y)
+115.2%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-94.8%
Return on assets
-55.3%
Debt / equity
0.4
Current ratio
6.2
EBITDA (TTM)
−$72.86M
Free cash flow (TTM)
−$27.53M
Quick ratio
5.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$30.22M
Latest balance sheet
Cash & equivalents
$43.46M
Total assets
$63.00M
Total debt
$13.23M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$27.07M
Capital expenditures (TTM)
$465,000
R&D (TTM)
$15.58M
SG&A (TTM)
—
Stock compensation (TTM)
$2.86M
R&D / revenue
94.2%
Stock compensation / revenue
17.3%

Ownership (13F)

9 metrics
13F filers
81
13F filer change QoQ
+29
Institutional ownership
20.6%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+17.5%
Holder tenure
9.3
Price vs estimated holder cost
-53.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
6.8%

Short interest

3 metrics
Short interest
3.7%
Latest settlement · 8.5 days to cover
Days to cover
8.5d
Short-squeeze score
57 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$12,545
Insider-sentiment score
44 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1833769 CUSIP 44916K106 13F (30d) 9 filings 9 filers Visit website Investor relations